Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

749 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule

NCT00752648

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins.

NCT00866853

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

NCT00703469

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Advanced Clinical Resesarch Institute Anaheim, California, United States

Quest Clinical Research San Francisco, California, United States

Springfield Clinic Infectious Diseases Springfield, Illinois, United States

John Hopkins University School of Medicine, Viral Hepatitis Center Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

NCT01038167

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Dallas, Texas, United States

View Trial Details

Completed

Antiviral Activity of AZD7295 in HCV Carriers

NCT00781976

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Prof Ed Gane Auckland, New Zealand

View Trial Details

Completed

Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

NCT00133276

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Erasmus MC University Hospital Rotterdam, South Holland, Netherlands

AMC Amsterdam, Netherlands

Radboud University Hospital Nijmegen, Netherlands

View Trial Details

Completed

Treatment of Cholestatic Pruritus With Sertraline

NCT00058903

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Blood-Borne Infections, +22 more
Locations: University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States

View Trial Details

Completed

Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

NCT00958152

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Christchurch, New Zealand

View Trial Details

Completed

Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial

NCT00983164

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Hospital Nereu Ramos Florianópolis, Santa Catarina, Brazil

Hospital Universitário Universidade Federal Santa Catarina Florianópolis, Santa Catarina, Brazil

Policlínica II Florianópolis, Santa Catarina, Brazil

View Trial Details

Completed

Safety Study of SPC3649 in Healthy Men

NCT00688012

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: PhaseOne Trials, Hvidovre University Hospital Hvidovre, Denmark

View Trial Details